Max India Limited (MAXIND.NS)

INR 298.74

(-1.83%)

EBITDA Summary of Max India Limited

  • Max India Limited's latest annual EBITDA in 2023 was -353.8 Million INR , down -567.41% from previous year.
  • Max India Limited's latest quarterly EBITDA in 2024 Q2 was -156.9 Million INR , up 29.58% from previous quarter.
  • Max India Limited reported an annual EBITDA of 116.6 Million INR in 2022, up 124.19% from previous year.
  • Max India Limited reported an annual EBITDA of -38.89 Million INR in 2021, down -10.23% from previous year.
  • Max India Limited reported a quarterly EBITDA of -156.9 Million INR for 2024 Q2, up 29.58% from previous quarter.
  • Max India Limited reported a quarterly EBITDA of -173.4 Million INR for 2023 Q3, down -1256.0% from previous quarter.

Annual EBITDA Chart of Max India Limited (2023 - 2017)

Historical Annual EBITDA of Max India Limited (2023 - 2017)

Year EBITDA EBITDA Growth
2023 -353.8 Million INR -567.41%
2022 116.6 Million INR 124.19%
2021 -38.89 Million INR -10.23%
2020 -300.29 Million INR -1137.3%
2019 -35.34 Million INR 90.01%
2018 -146.13 Million INR 28.03%
2017 -245.53 Million INR 0.0%

Peer EBITDA Comparison of Max India Limited

Name EBITDA EBITDA Difference
Apollo Hospitals Enterprise Limited 24.02 Billion INR 101.473%
Artemis Medicare Services Limited 1.24 Billion INR 128.396%
Aster DM Healthcare Limited 6.11 Billion INR 105.785%
Fortis Healthcare Limited 13.07 Billion INR 102.706%
HealthCare Global Enterprises Limited 3.5 Billion INR 110.096%
Indraprastha Medical Corporation Limited 2.1 Billion INR 116.828%
Krishna Institute of Medical Sciences Limited 6.61 Billion INR 105.352%
Lotus Eye Hospital and Institute Limited 79.42 Million INR 545.46%
Max Healthcare Institute Limited 16.7 Billion INR 102.118%
Global Health Limited 8.71 Billion INR 104.058%
Narayana Hrudayalaya Limited 12.42 Billion INR 102.847%
Rainbow Children's Medicare Limited 4.69 Billion INR 107.537%
Shalby Limited 1.98 Billion INR 117.864%